531146 Stock Overview
Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Medicamen Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹434.10 |
| 52 Week High | ₹903.50 |
| 52 Week Low | ₹356.75 |
| Beta | 1.34 |
| 1 Month Change | 5.39% |
| 3 Month Change | -19.07% |
| 1 Year Change | -38.88% |
| 3 Year Change | -15.64% |
| 5 Year Change | -15.53% |
| Change since IPO | 2,989.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531146 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.7% | -0.1% | 1.8% |
| 1Y | -38.9% | 55.9% | 46.4% |
Return vs Industry: 531146 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 531146 underperformed the Indian Market which returned 46.1% over the past year.
Price Volatility
| 531146 volatility | |
|---|---|
| 531146 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531146's share price has been volatile over the past 3 months.
Volatility Over Time: 531146's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 388 | Rajesh Madan | medicamen.com/ |
Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products.
Medicamen Biotech Limited Fundamentals Summary
| 531146 fundamental statistics | |
|---|---|
| Market cap | ₹5.52b |
| Earnings (TTM) | ₹126.93m |
| Revenue (TTM) | ₹1.71b |
43.5x
P/E Ratio3.2x
P/S RatioIs 531146 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531146 income statement (TTM) | |
|---|---|
| Revenue | ₹1.71b |
| Cost of Revenue | ₹920.06m |
| Gross Profit | ₹786.46m |
| Other Expenses | ₹659.53m |
| Earnings | ₹126.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.98 |
| Gross Margin | 46.09% |
| Net Profit Margin | 7.44% |
| Debt/Equity Ratio | 14.5% |
How did 531146 perform over the long term?
See historical performance and comparison